Catalyst Wire Dossier Catalyst Wire Dossier

Imatinib Teva

imatinib · Teva B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imatinib Teva, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: EMA Authorised: Imatinib Teva (imatinib) — Teva B.V.

See pricing